ArticleTargeted oncology2026
Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR Trial.
Yu Sunakawa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.